Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.5150
-0.0350 (-6.36%)
At close: Jun 5, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 70.48 million as of June 5, 2026. Its market cap has increased by 46.27% in one year.
Market Cap
70.48M
Enterprise Value
61.06M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.52
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 70.48M, an increase of 174.26%. That is a compound annual growth rate of 43.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 70.48M | -14.88% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 171.21M |
| EMVision Medical Devices | 157.09M |
| SomnoMed | 131.45M |
| Saluda Medical | 118.45M |
| Lumos Diagnostics Holdings | 97.01M |
| Epiminder | 82.21M |
| Compumedics | 50.94M |
| HeraMED | 48.61M |